Macrogen, Inc. (KOSDAQ:038290)
11,250
+220 (1.99%)
Jul 21, 2026, 3:30 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 121.97 billion as of July 21, 2026. Its market cap has decreased by -29.51% in one year.
Market Cap
121.97B
Enterprise Value
174.91B
Revenue
199.60B
Ranking
n/a
PE Ratio
32.10
Stock Price
11,250.00
ChartMarket Cap Chart
Since September 14, 2000, Macrogen's market cap has decreased from 148.29B to 121.97B, a decrease of -17.75%. That is a compound annual growth rate of -0.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 121.97B | -33.31% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 200.46B |
| Anterogen.Co.,Ltd. | 183.21B |
| HLB Therapeutics | 171.62B |
| JETEMA, | 165.93B |
| Helixmith | 160.93B |
| Bioneer | 160.02B |
| NeoImmuneTech | 134.86B |
| Genexine | 106.88B |